Details for New Drug Application (NDA): 072097
✉ Email this page to a colleague
NDA 072097 describes CAP-PROFEN, which is a drug marketed by Perrigo and is included in one NDA. Additional details are available on the CAP-PROFEN profile page.
The generic ingredient in CAP-PROFEN is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and thirty-eight suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
The generic ingredient in CAP-PROFEN is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and thirty-eight suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 072097
| Tradename: | CAP-PROFEN |
| Applicant: | Perrigo |
| Ingredient: | ibuprofen |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 072097
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
| Approval Date: | Dec 8, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
